Jeffrey V. Lazarus

78.0k citations
341 papers · 9.9k · 13 hit papers · h-index 42

Impact in

  • Health top 0.05%
    • Vaccine Coverage and Hesitancy
  • Hepatology top 0.2%
    • Hepatitis C virus research

Papers in

    • Liver Disease Diagnosis and Treatment 84
    • Hepatitis B Virus Studies 48
    • HIV, Drug Use, Sexual Risk 45
    • Hepatitis C virus research 85
    • Liver Disease and Transplantation 19

Jeffrey V. Lazarus

317 papers receiving 9.6k citations

Jeffrey V. Lazarus's Hit Papers

Metabolic dysfunction-associated steatotic liver disease in adults 2025 · 92 citations
920+2+5Years since publication50010001.5k2.0k

Peers

Jeffrey V. Lazarus
Comparison fields: 5 of 183
  • Health 2.6k
  • Hepatology 2.0k
  • Modeling and Simulation 786
  • Infectious Diseases 2.0k
  • Epidemiology 3.1k
Replace Charles Shey Wiysonge with:
Charles Shey Wiysonge South Africa
Tom Jefferson United Kingdom
Patrick S. Sullivan United States
Zunyou Wu China
Damian Walker United Kingdom
Tim Rhodes United Kingdom
Yot Teerawattananon Thailand
Andrew Copas United Kingdom
Kumanan Wilson Canada
Daniel A. Salmon United States
Jeffrey V. Lazarus relative to Charles Shey Wiysonge South Africa Charles Shey Wiysonge's profile →
Citations per field
00.5×10×12.8×
Charles Shey Wiysonge · 1×
Citations per year

Countries citing papers authored by Jeffrey V. Lazarus

Since Specialization
Citations

This map shows the geographic impact of Jeffrey V. Lazarus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey V. Lazarus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey V. Lazarus more than expected).

Fields of papers citing papers by Jeffrey V. Lazarus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey V. Lazarus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey V. Lazarus. The network helps show where Jeffrey V. Lazarus may publish in the future.

Co-authors

The 25 scholars most cited alongside Jeffrey V. Lazarus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jeffrey V. Lazarus Line = papers co-authored together Jeffrey V. Lazarus links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 341 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A global survey of potential acceptance of a COVID-19 vaccine
Hit paper breakdown →
20202082
2
Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies
Hit paper breakdown →
2018501
3
Reply: A multi-society Delphi consensus statement on new fatty liver disease nomenclature
Hit paper breakdown →
2023279
4
Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021
Hit paper breakdown →
2022270
5
A survey of COVID-19 vaccine acceptance across 23 countries in 2022
Hit paper breakdown →
2023240
6 2020182
7 2020175
8 2014175
9
Non-alcoholic fatty liver disease: A patient guideline
Hit paper breakdown →
2021173
10 2020163
11 2018158
12 2020133
13
A multinational Delphi consensus to end the COVID-19 public health threat
Hit paper breakdown →
2022128
14 2019121
15 2009120
16
HIV infection
Hit paper breakdown →
2023112
17 2020111
18
SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties
Hit paper breakdown →
2021106
19 201992
20
Metabolic dysfunction-associated steatotic liver disease in adults
Hit paper breakdown →
202592

About Jeffrey V. Lazarus

Jeffrey V. Lazarus is a scholar working on Epidemiology, Hepatology, Infectious Diseases, General Health Professions and Economics and Econometrics, having authored 341 papers that have together received 9.9k indexed citations. Recurring topics across this work include Hepatitis C virus research (85 papers), Liver Disease Diagnosis and Treatment (84 papers), Hepatitis B Virus Studies (48 papers), HIV/AIDS Research and Interventions (46 papers), HIV, Drug Use, Sexual Risk (45 papers), Vaccine Coverage and Hesitancy (21 papers), Liver Disease and Transplantation (19 papers) and Alcohol Consumption and Health Effects (18 papers). The work is most often cited by research in Health (2.6k citations), Hepatology (2.0k citations), Modeling and Simulation (786 citations), Infectious Diseases (2.0k citations) and Epidemiology (3.1k citations). Jeffrey V. Lazarus has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Ayman El-Mohandes, Scott C. Ratzan, Kenneth Rabin, Heidi J. Larson, Adam Palayew, Lawrence O. Gostin, Spencer Kimball, Trenton M. White, Camila A Picchio and Helena Cortez‐Pinto. Their work appears in journals such as Journal of Hepatology, HIV Medicine, Liver International, Nature Reviews Gastroenterology & Hepatology and International Journal of Drug Policy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact